I graduated from Barts and the London School of Medicine and Dentistry in 1998, having also obtained an intercalated BSc in Tumour Biology at University College London (1995). After junior medical training in London, including oncology posts at Barts and the Royal Marsden Hospitals, I commenced my Medical Oncology training at Barts before undertaking a PhD in Molecular Oncology and completed my medical oncology training in Wessex. I was appointed as a Consultant in Reading at the Royal Berkshire Hospital in January 2012.
I specialise in the treatment of melanoma, breast and ovarian cancers with systemic treatments. I am also the Acute Oncology Lead for the Thames Valley and the Royal Berkshire Hospitals.
I see private patients at Spire Dunedin Hospital.
As well as my clinical interests, I have an interest in education and am educational supervisor for medical trainees at Royal Berkshire Hospital. In 2015, I edited Challenging Concepts in Oncology, a textbook of clinical scenarios in oncology and recently updated the breast cancer, ovarian cancer and melanoma chapters in the Oxford Handbook of Oncology.
I have a number of publications in peer-reviewed journals.
I am keen for my patients to have access to clinical trials and am principal investigator on trials in ovarian and breast cancers.
I was awarded a CRUK Clinical Research Fellowship investigating the role of adenoviral gene therapy in pancreatic cancer and was awarded a PhD in 2008.
I have published in a number of peer-reviewed journals and written book chapters. Selected articles are listed below.
Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer (2007)
Intermittent dosing with vemurafenib in BRAF V600E-mutant melanoma: review of a case series (2014)
Agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. (2015).
Editor of Challenging Concepts in Oncology, OUP, 2015
Author of “Cancer of Unknown Primary” chapter in Challenging Concepts in Oncology.
I have previously accepted educational grants to fund attendance at national and international cancer conferences and have received payment at educational meetings sponsored by the pharmaceutical industry. I make full disclosures and have no financial interests in any pharmaceutical company.
I am an investor in the Genesis Care,Windsor, Diagnostic and Oncology Centre.